Yüklüyor......
Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
Atrial fibrillation is the most frequent arrhythmia in clinical practice, reaching 2% of the people in the world and is associated with systemic embolism. Thus, the use of anticoagulants is indicated if CHA2DS2-VASc score ≥2 or in patients with previous transient ischemic attack or stroke. For decad...
Kaydedildi:
| Yayımlandı: | Cardiovasc Hematol Agents Med Chem |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Bentham Science Publishers
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4428103/ https://ncbi.nlm.nih.gov/pubmed/25470147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/187152571201141201091848 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|